Title Expression of glycoprotein non-metastatic melanoma protein B in prostate cancer and its significance
Authors Xiao Yun-bei
Qiao Zheng-guo
Zhang Xiao-wei
Liu Zhen-hua
Xie Jing
Hao Yi-chang
Yu Wei-dong
Xu Tao
Wang Xiao-feng
Affiliation Department of Urology, Peking University People's Hospital, Beijing 100044, China.
Issue Date 2011
Publisher 开云app体育 学报 医学版
Citation Beijing da xue xue bao. Yi xue ban.2011,43,(4),496-9.
Abstract To investigate the expression of glycoprotein non-metastatic melanoma protein B (GPNMB) in prostate cancer and its clinical significance.The expression of GPNMB was analysed in 63 prostate cancer and 3 heterosexual hyperplasia prostate tissue and 8 benign prostatic hyperplasia samples by immunohistochemical staining, with integral optical density(IOD) value representing expression level of positive cells.The expression of GPNMB was lower in benign prostatic hyperplasia (BPH, IOD=70 017.49) than in Atypical hyperplasia (IOD=101 547.33, P=0.000 1) . The expression of GPNMB in tumor (IOD= 162 027.54) was higher than in non-tumor group (IOD=79 290.97), which included BPH and atypical hyperplasia (P=0.000 1). But GPNMB expression level was not positively elevated with degree of malignancy of prostate cancer. However, the expression of GPNMB in low pathological grading(IOD=177 944.30) was higher than that in high pathological grading(IOD=150 885.81, P=0.013).The abnormal expression of GPNMB may play an important role in the development of prostate cancer and its detection may be useful for the early diagnosis of prostate cancer.
URI http://hdl.handle.net/20.500.11897/307318
ISSN 1671-167X
Indexed PubMed
Appears in Collections: 人民医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

百度学术™


0

Checked on Current Time




License: See PKU IR operational policies.